Loncar Investments

  • Loncar China Biopharma ETF

Loncar China Biopharma ETF

Quarterly Returns



Years Q1 Q2 Q3 Q4 Annual
2018 0% 0% -3% -17% -63.4%
2019 23.8% -7.9% -3.9% 13.7% 29.3%
2020 -8.4% 35.3% -0.5% -4.6% 17.6%
2021 13.3% 43.9% -29.8% -19.9% -8.2%
2022 -23.5% -2.3% -28.2% 30.7% -29.9%
2023 -5.1% -9.2% -11.9% -4.6% -27.9%
2024 0% 0% 0% 0% 0%
Data SourcesDisclaimer